Cargando…
The DNA Damage Response and HIV-Associated Pulmonary Arterial Hypertension
The HIV-infected population is at a dramatically increased risk of developing pulmonary arterial hypertension (PAH), a devastating and fatal cardiopulmonary disease that is rare amongst the general population. It is increasingly apparent that PAH is a disease with complex and heterogeneous cellular...
Autores principales: | Simenauer, Ari, Nozik-Grayck, Eva, Cota-Gomez, Adela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246454/ https://www.ncbi.nlm.nih.gov/pubmed/32392789 http://dx.doi.org/10.3390/ijms21093305 |
Ejemplares similares
-
Peptide-Coated Liposomal Fasudil Enhances Site Specific
Vasodilation in Pulmonary Arterial Hypertension
por: Nahar, Kamrun, et al.
Publicado: (2014) -
DNA Damage and Repair in Pulmonary Arterial Hypertension
por: Sharma, Samantha, et al.
Publicado: (2020) -
Platelet activation in experimental murine neonatal pulmonary hypertension
por: Davizon‐Castillo, Pavel, et al.
Publicado: (2020) -
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
por: Al-Hilal, Taslim A., et al.
Publicado: (2020) -
Heart of the Matter: Divergent Roles of Hypoxia-Inducible Factors in
Hypoxia-induced Right Ventricle Hypertrophy
por: Nozik-Grayck, Eva, et al.
Publicado: (2020)